Center for Clinical and Cognitive Neuropharmacology
Investigating How Drugs Affect Cognition
The Center for Clinical and Cognitive Neuropharmacology pioneers innovative and multidisciplinary research on the impact of drugs on cognition.
Enhancing Clinical Strategies
Cognitive impairment is a widely reported side effect of many commonly used drugs. The CCCN is developing novel approaches and tools for assessment of drug effects on cognition and behavior to predict individual patient response.
Breaking New Ground
The CCCN researchers are investigating drugs used to treat a variety of medical conditions, from mental illness to epilepsy to cancer, that have been associated clinically with adverse cognitive side effects. The work of the Center will guide new drug development, enhance the ability to personalize medication therapy and examine the ethical and public policy implications resulting from the use of cognitive-altering agents in pediatric and adult populations.